Pharmacopsychiatry 2005; 38(6): 301-311
DOI: 10.1055/s-2005-916185
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

E. Gouzoulis-Mayfrank1 , K. Heekeren1 , 2 , A. Neukirch1 , 2 , M. Stoll2 , C. Stock2 , M. Obradovic3 , K.-A. Kovar3
  • 1Department of Psychiatry and Psychotherapy, University of Cologne, Kerpener Strasse 62, Cologne, Germany
  • 2Department of Psychiatry and Psychotherapy, University of Technology, Aachen (RWTH), Pauwelsstrasse 30, Aachen, Germany
  • 3Institute of Pharmacy, University of Tübingen, Auf der Morgenstelle 8, Tübingen, Germany
Further Information

Publication History

Received: 11.3.2005 Revised: 8.6.2005

Accepted: 14.7.2005

Publication Date:
08 December 2005 (online)

Introduction: Pharmacological challenges with hallucinogens are used as models for psychosis in experimental research. The state induced by glutamate antagonists such as phencyclidine (PCP) is often considered as a more appropriate model of psychosis than the state induced by serotonergic hallucinogens such as lysergic acid diethylamide (LSD), psilocybin and N,N-dimethyltryptamine (DMT). However, so far, the psychological profiles of the two types of hallucinogenic drugs have never been studied directly in an experimental within-subject design. Methods: Fifteen healthy volunteers were included in a double-blind, cross-over study with two doses of the serotonin 5-HT2A agonist DMT and the glutamate N-methyl-d-aspartate (NMDA) antagonist (S)-ketamine. Results: Data are reported for nine subjects who completed both experimental days with both doses of the two drugs. The intensity of global psychological effects was similar for DMT and (S)-ketamine. However, phenomena resembling positive symptoms of schizophrenia, particularly positive formal thought disorder and inappropriate affect, were stronger after DMT. Phenomena resembling negative symptoms of schizophrenia, attention deficits, body perception disturbances and catatonia-like motor phenomena were stronger after (S)-ketamine. Discussion: The present study suggests that the NMDA antagonist model of psychosis is not overall superior to the serotonin 5-HT2A agonist model. Rather, the two classes of drugs tend to model different aspects or types of schizophrenia. The NMDA antagonist state may be an appropriate model for psychoses with prominent negative and possibly also catatonic features, while the 5-HT2A agonist state may be a better model for psychoses of the paranoid type.

References

Professor Euphrosyne Gouzoulis-Mayfrank, MD

Department of Psychiatry and Psychotherapy

University of Cologne

Kerpener Straße 62

50924 Cologne

Germany

Phone: +49 221 478 4825

Fax: +49 221 478 3738

Email: e.gouzoulis@uni-koeln.de